logo
Plus   Neg
Share
Email

Spark Therapeutics' One-time Gene Therapy LUXTURNA Gets EU Approval

Spark Therapeutics (ONCE), a commercial gene therapy company, announced Friday that the European Commission has granted marketing authorization for LUXTURNA (voretigene neparvovec).

LUXTURNA is a one-time gene therapy for the treatment of adult and pediatric patients with vision loss due to inherited retinal dystrophy caused by confirmed biallelic RPE65 mutations and who have sufficient viable retinal cells.

This authorization is valid in all 28-member states of the EU, as well as Iceland, Liechtenstein and Norway. LUXTURNA is the first and only gene therapy approved in EU for patients with an inherited retinal disease or IRD.

It is also the first gene therapy for a genetic disease that has received regulatory approval in both the U.S. and EU.

RPE65-mediated IRD is a progressive condition leading to total blindness in most patients.

In January 2018, Spark entered into a licensing agreement with Novartis to commercialize LUXTURNA when approved in Europe and all other markets outside the U.S.

Spark will manufacture and supply LUXTURNA for Novartis, while Novartis has exclusive rights to pursue development, registration and commercialization in all other countries outside the U.S.

In September 2018, the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency adopted a positive opinion recommending approval of LUXTURNA.

LUXTURNA was approved by the U.S. Food & Drug Administration (FDA) in December 2017.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
U.S. President Donald Trump said he discussed with Apple Inc.'s CEO Tim Cook about the impact of the U.S. tariffs on goods imported from China as well as the competition for Apple from South Korea's Samsung Electronics Co. Cook reportedly warned Trump that the tariffs on Chinese imports would hurt Apple's business as the tech giant relies heavily on manufacturing in China. Just Egg, a plant-based egg alternative, will be available in 2,100 stores owned by grocery chain Kroger Co. later this month. The product launch comes as plant-based meat and egg alternatives gain traction in the country. Just Egg, a product of California-based food technology company Just Inc., will be available at Kroger-owned stores, including Kroger, Fred Meyer and Ralphs. Boeing has delivered the first 787-10 Dreamliner to Vietnam Airlines, the flag carrier of Vietnam, as part of the eight 787-10 Dreamliner airplanes to be delivered on lease through Air Lease. Vietnam Airlines said the 787-10 Dreamliner, claimed by Boeing to be the most fuel-efficient twin-aisle airplane in the industry, will help it raise the customer experience on the Hanoi to Ho Chi Minh route.